MSLN and cancer: In relation to cancer, MSLN is overexpressed not only in CRC, but also in pancreatic, ovarian, lung, gastric, cervical, endometrial and biliary cancers, malignant pleural mesothelioma, uterine serous carcinoma, cholangiocarcinoma and paediatric acute myeloid leukaemia [61,62].